Clinical
Evidence
> Clinical trials to date
> Initial publication -Phlebology
> Management of foot and leg ulcers
> A randomised controlled trial: Kerraboot
vs Allevyn®
> Kerraboot – benefits of treatment> Beyond lower limb ulcers:
> surgical debridement
and skin grafting
In a comparative study of Kerraboot versus Allevyn, a standard dressing, in diabetic
foot ulcers in the community the overall healing profile of the Kerraboot group
showed greater improvements in granulation and reduced ‘sloughing’ even
though these patients had worse ulcers to start with than the standard group.
Also, greater improvements were noted in pain reduction and stress indicators
versus standard therapy. In comparison to standard dressings, Kerraboot resulted
in a 50% reduction in the time needed by nurses to change the dressing and all
patients rapidly became nurse-independent, being able to change the dressing themselves.
In terms of acceptability, the healthcare workers and patients rated the Kerraboot
better for most parameters tested, notably ease of application and removal, convenience
and improved patient mobility.
Edmonds M, Foster A, Jemmott T, Kerr
D, Malik R, Knowles A, Jude E, Chadwick PJ, Rahaman L, Murray N. Randomised study
of Kerraboot vs standard wound care in the management of diabetic neuropathic
foot ulcers. Wounds UK 2006:2(1) 25-30
Back to the top |
